Key Echocardiographic Parameters for Preoperative Anesthesia Assessment
The most critical echo parameters to document preoperatively are left ventricular ejection fraction (LVEF), left ventricular dimensions (LVEDD/LVESD), diastolic function parameters (E/e' ratio, left atrial volume index), right ventricular function (TAPSE, S' wave), and pulmonary artery systolic pressure (PASP), as these directly predict perioperative cardiac complications and guide anesthetic management. 1
Left Ventricular Systolic Function
LVEF - The Primary Metric
- LVEF <35-40% significantly increases perioperative risk of cardiac death, MI, and heart failure, with sensitivity of 50% and specificity of 91% for predicting perioperative complications 1
- Normal LVEF ranges: 53-73% by 2D methods, >54% for men and >57% for women by 3D echocardiography 2
- Critical threshold: LVEF <40% warrants heightened perioperative monitoring and may require optimization before elective surgery 1
- Note that general anesthesia itself reduces LVEF by approximately 8-9% in patients with dilated ventricles, and even patients with normal baseline function can drop into dysfunction range (28% of normal patients had LVEF <50% under anesthesia) 3
LV Dimensions and Volumes
- LVEDD >56 mm indicates ventricular dilatation and predicts greater hemodynamic instability with anesthesia 4
- LVEDD >70 mm with preserved LVEF represents severe dilatation requiring careful fluid management 5
- LVEDD ≥81 mm is associated with significantly worse outcomes even with preserved LVEF 5
- LVESD >45 mm or >25 mm/m² indicates systolic dysfunction 1
- Volumes should be indexed to body surface area: LVEDV index <80 mL/m² (men), <72 mL/m² (women) 1
Diastolic Function Assessment
E/e' Ratio - Filling Pressure Surrogate
- E/e' ratio is the single most validated parameter for estimating left ventricular filling pressures, with pooled correlation coefficient of 0.56 with invasive measurements 1
- E/e' ≥13 suggests elevated filling pressures and increased risk of perioperative pulmonary edema 1
- Each unit increase in E/e' carries a hazard ratio of 1.05 for adverse outcomes 1
- E/e' ≥2 combined with deceleration time <150 ms indicates significantly elevated LV filling pressures 1
Left Atrial Volume Index (LAVI)
- LAVI ≥34 mL/m² indicates chronic diastolic dysfunction and elevated filling pressures 1
- LAVI >40 mL/m² combined with elevated tricuspid regurgitation velocity significantly increases risk 1
- LA volume provides prognostic information independent of LVEF 1
Right Ventricular Function and Pulmonary Pressures
PASP and Pulmonary Hypertension
- Peak tricuspid regurgitation velocity >3 m/s (PASP >40 mmHg) indicates pulmonary hypertension requiring specific anesthetic considerations 1
- PASP 40-50 mmHg suggests moderate pulmonary hypertension; >60 mmHg indicates severe disease 1
- Mean pulmonary artery pressure (mPAP) <29 mmHg is a favorable prognostic indicator for perioperative outcomes 4
- Calculate pulmonary vascular resistance when PASP is elevated: PVR = (mPAP - PCWP)/cardiac output, with normal <2-3 Wood units 6
RV Function Parameters
- TAPSE <16 mm indicates RV systolic dysfunction and predicts adverse perioperative outcomes (HR 2.59) 7
- Normal TAPSE: 17-20 mm or greater 7
- S' wave velocity <10 cm/s suggests RV dysfunction, with S'/PASP ratio <0.22 indicating poor RV-pulmonary coupling 7
- TAPSE/PASP ratio <0.37-0.49 indicates RV-pulmonary uncoupling and significantly worse prognosis 7
- RV end-diastolic diameter (RVEDD) >44 mm suggests RV dilatation 7
Advanced Parameters for High-Risk Cases
Global Longitudinal Strain (GLS)
- LV GLS >-16% (less negative) indicates subclinical LV dysfunction even with preserved LVEF 2
- Normal LV GLS: >-20% (more negative than -20%) 1, 2
- General anesthesia reduces LV GLS from -19.1% to -17.3%, pushing 28% of normal patients into dysfunction range 3
- RV free wall strain >-24% (less negative) indicates RV dysfunction, with normal >-23% 2, 3
LV Mass Index
- LV mass index helps identify LV hypertrophy, which independently predicts perioperative complications 1
- Presence of LV hypertrophy carries hazard ratio of 1.59 for adverse outcomes 1
Critical Clinical Thresholds Summary
For patients with reduced LVEF (<50%):
- Focus on LVEF absolute value, TAPSE, TAPSE/PASP ratio, and IVC diameter 7
- TAPSE <16 mm and TAPSE/PASP <0.49 are strongest predictors of poor outcome 7
For patients with preserved LVEF (≥50%):
- Focus on E/e' ratio, S' wave velocity, S'/PASP ratio, and LAVI 7
- S'/PASP <0.22 is strongest predictor of adverse outcome 7
Common Pitfalls to Avoid
- Do not rely on visual estimation of LVEF alone—quantitative measurement by biplane Simpson's method or 3D echo is essential, as different methods yield different values 8
- Recognize that anesthesia and positive pressure ventilation suppress both LV and RV function by 8-9% and 9% respectively, even in patients without myocardial disease 3
- PASP estimated by echo has limited positive predictive value (25-64%) for confirming pulmonary hypertension—consider right heart catheterization for definitive assessment in borderline cases 6
- E/e' ratio can be misleading in atrial fibrillation, severe mitral regurgitation, and with pacemakers—use additional diastolic parameters for confirmation 1
- Document timing relative to dialysis in renal patients, as volume status dramatically affects all measurements 1
- Record blood pressure, heart rate, and rhythm at time of echo, as these affect interpretation of all parameters 1